A. Lin

Impacts of dystrophin and utrophin domains on actin structural dynamics: implications for therapeutic design.

B. Li, J. Ervasti, David D. Thomas, 2012, Journal of molecular biology.

Dynamics of Dystrophin's Actin-Binding Domain.

David D. Thomas, Andrew R. Thompson, Alessandro Cembran, 2018, Biophysical journal.

Beta cap73: a novel beta actin-specific binding protein.

I. Herman, C. B. Shuster, A. Y. Lin, 1996, Cell motility and the cytoskeleton.

Neurological and Neuroradiological Manifestations in Neonates Born to Mothers With Coronavirus Disease 2019

A. Srinivasan, T. Moritani, John Kim, 2022, Pediatric Neurology.

Biosynthesis of a 3,6-dideoxyhexose: crystallization and X-ray diffraction of CDP-6-deoxy-L-threo-D-glycero-4-hexulose-3-dehydrase (E1) for ascarylose biosynthesis.

Hung‐wen Liu, S. Tsai, Peter W. Smith, 2006, Acta crystallographica. Section F, Structural biology and crystallization communications.

From structure and dynamics to novel therapeutic development for muscular dystrophy.

A. Lin, 2012 .

The carboxy-terminal third of dystrophin enhances actin binding activity.

J. Ervasti, David D. Thomas, D. Henderson, 2012, Journal of molecular biology.

Molecular Therapies for Muscular Dystrophies

Leo H. Wang, A. Lin, 2018, Current Treatment Options in Neurology.

Large-scale opening of utrophin’s tandem calponin homology (CH) domains upon actin binding by an induced-fit mechanism

David D. Thomas, B. Svensson, Zachary M James, 2011, Proceedings of the National Academy of Sciences.

Optimizing hand-function patient outcome measures for inclusion body myositis

C. Weihl, A. Faino, Leo H. Wang, 2020, Neuromuscular Disorders.

A cross-sectional study of hand function in inclusion body myositis: Implications for functional rating scale

C. Weihl, Kevin Dooley, Leo H. Wang, 2019, Neuromuscular Disorders.